[Results of the North-Baden venous lysis study. Randomized trial of the effect of ultra-high streptokinase versus conventional streptokinase dosage].
We compared the effect between ultra-high-streptoinase therapy and standard fibrinolysis in a prospective randomized multicenter study of deep vein thrombosis. Ultra-high doses group seems to be a better treatment including decreasing the side-effects, but without showing statistical significance.
Heinrich
U
U
Medizinische Klinik, Diakonissenkrankenhauses Mannheim.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001458:Bandages; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010690:Phlebography; D013300:Streptokinase / Q000008:administration & dosage* / Q000009:adverse effects; D013924:Thrombophlebitis / Q000000981:diagnostic imaging / Q000628:therapy*
D013300:Streptokinase
Ergebnisse der Nordbadischen Venen-Lyse-Studie. Randomisierte Prüfung der Wirkung von UHSK versus konventionell dosierter Streptokinase.